Definitive Contract HHSN272201500008C
Award Date
6/30/15
Potential Completion Date
10/31/18
Potential Value
$3.5M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Emory University
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Atlanta, GA 30322, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
24
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Emory University, a private research institution in Atlanta, Georgia, by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH). The contract, valued at $1,056,666.00, is for a task order under an existing Indefinite Delivery Contract (IDC) held by Emory with NIAID. This IDC, with a ceiling value of $146,300,000 and a performance period through July 2031, enables Emory to provide NIAID with the...
This is a federal contract award to Emory University, a private research institution in Atlanta, Georgia. The contract, valued at $10,564,646.55, is a delivery order under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Contract with the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract supports Emory's research and services related to the VTEU program, which focuses on the...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Emory University, a private university and research institution located in Atlanta, Georgia. The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which focuses on the development and evaluation of vaccines and treatments for infectious diseases. The contract has a total potential value of $263,956.53 and a period of performance ending on...
This federal contract award was made by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Emory University to conduct research and development on the antiviral drug EIDD-2801. The contract has a potential value of $1,108,746.46 and runs from September 9, 2019 through July 31, 2020. The contract is a definitive contract with cost reimbursement pricing and does not have a set-aside designation. Emory University, a...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Emory University, a private research institution in Atlanta, Georgia. The contract, valued at $17,242,506.00, is for the NIH TCF BASE YEAR 1 TASK A-1 project, which runs from March 21, 2020, to March 20, 2021, with a potential completion date of March 20, 2027. The contract is a Delivery Order under a larger Indefinite Delivery...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Emory University, a private research institution, with a ceiling value of $1,050,622.47. The delivery order is under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Contract, which enables NIAID to fund research and development of medical countermeasures against infectious diseases, including those...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Emory University, a private research institution in Atlanta, Georgia. The contract, valued at $6,963,671.38, is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports the development and evaluation of vaccines and treatments for infectious diseases. The contract has no set-aside designation. Emory University,...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Emory University, a private research institution in Atlanta, Georgia. The contract is part of NIAID's Vaccine and Treatment Evaluation Units (VTEU) program, which supports the evaluation of vaccines and treatments for infectious diseases. The contract has a ceiling value of $3,128,475.78 and a period of performance through December...
<p>The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $879,633 cost no fee delivery order contract to Emory University Office Of Sponsored Programs Division for TASK ORDER B-4 covering the period from August 1, 2022 through March 20, 2027. The contract supports the National Interest Action Code of Coronavirus COVID-19. Performance will take place in Atlanta, Georgia.</p>
This is a $6,223,512.88 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, for "Targeted Clinical Research to Address Select Viral Infections". The contract has no set-aside designation. The prime contractor is Northwestern University, a private research university, which will be supported by multiple academic subcontractors including Georgetown University, Vanderbilt University...